1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections : A Nationwide Study
(
- Contribution to journal › Article
-
Mark
Histologic Remission in Inflammatory Bowel Disease and Female Fertility : A Nationwide Study
(
- Contribution to journal › Article
-
Mark
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
(
- Contribution to journal › Article
- 2023
-
Mark
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease : A Retrospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis : A Scandinavian Cohort Study
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
- 2022
-
Mark
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes : A nationwide study
(
- Contribution to journal › Article
-
Mark
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases : A Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Association Between Inflammatory Bowel Disease and Spondyloarthritis : Findings from a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease : results from nationwide Swedish registers
(
- Contribution to journal › Article